Verition Fund Management LLC Annexon, Inc. Transaction History

Verition Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.33 - $6.79 $43,464 - $68,158	10,038 New	10,038 $49,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $3.84 $40,470 - $72,960	19,000 New	19,000 $44,000
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $95,550 - $417,900	-35,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.49 - $22.0 $402,150 - $770,000	35,000 New	35,000 $402,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $245M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.